30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Johnson & Johnson to Acquire Remaining Stake in Verb Surgical -

Johnson & Johnson, parent company to DePuy Synthes Companies, entered into an agreement to acquire the remaining ownership stake in Verb Surgical. The transaction is expected to close in the first half of 2020. Verb's robotics and data science capabilities are expected to bolster JNJ's healthcare leadership and global reach while making medical interventions smarter, less invasive and more personalized. While Verb Surgical is a separate development project from others, such as VELYS™, the company will seek to leverage insights across the organization. JNJ has continued to grow its digital surgery portfolio, combining robotics, enhanced visualization, advanced instrumentation, machine learning, data analytics and end-to-end connectivity. Its 2019 acquisition of robotics company Auris Health accelerated JNJ's entry into digital surgery with Monarch, addressing non-orthopedic applications but leading a strong cadence of launches expected over the next several years. In 2018, JNJ acquired Orthotaxy, developer of a robot-assisted system for total and partial knee reconstruction. JNJ's VELYS Digital Surgery platform, introduced in 2019, will pave the way in orthopedics with a platform that comprises connected technologies that leverage data insights for patients, surgeons and health care systems across the entire care continuum, before, during and after surgery.